GlucoSet's critical care monitoring solutions enable clinics to reduce complications and cost.  The company's real-time, intra-vascular, hydrogel-based continuous glucose monitor delivers constant accurate information on blood glucose levels, making continuous glucose control in the ICU a reality.

Founded in

2011

CEO

Nicolas Elvemo

Invested since

2023

Part of our

Diabetes Venture Fund

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

This website is using necessary cookies to provide a good browsing experience, see our Cookie Policy. These include essential cookies that are necessary for the operation of the siteor for comfort settings.

Your cookie preferences have been saved.